Ewha Mokdong Hospital ER Bio Core Project Team Leads the Development of Next-Generation Medical Innovation Companies

Ewha Mokdong Hospital ER Bio Core Project Team (led by Director Yoo Kyung-ha, President of Ewha Medical Center) reported achieving significant results by supporting hospital infrastructure and commercialization through the Korean Research Foundation’s Bio Core Facility Construction Project.

In the 7-year, 11.1 billion KRW project, five companies were selected: ▲Neurosona, ▲SKIA, ▲SynergyAI, ▲Excellence, and ▲TS Bio. Since December 2022, these companies have received support from Ewha Mokdong Hospital to develop innovative technologies.

Neurosona has developed a technology that non-invasively controls specific areas of the brain using ultrasound technology. Phase 1 clinical trials, conducted in collaboration with Ewha Mokdong Hospital, were successfully completed, and they are now preparing for Phase 2 trials.

SKIA has developed technology that accurately matches medical images, such as CT/MRI scans, with real-time camera images, displaying the location of lesions on smart devices.

SynergyAI is a company that develops AI solutions to assist medical diagnoses. It was founded by Professor Shin Tae-young of Ewha Mokdong Hospital’s Department of Urology. In collaboration with Professor Park Jun-beom from the hospital's Department of Cardiology, they developed the Mac'AI solution for arrhythmia prediction, which can diagnose without requiring hospital visits or numerous sensor attachments. The accuracy of the solution is 92.72%.

Excellence, founded by Professor Kwon Ki-hwan from Ewha Mokdong Hospital’s Department of Cardiology, has developed a pancreatic cancer treatment project, 'EB-TM1', using their proprietary 'SWEET™' technology for large-scale production of exosomes with high drug encapsulation efficiency. This project was selected for the National New Drug Development Project in 2023.

Lastly, TS Bio signed a licensing-out agreement for the technology of 'separation, cultivation, and cryopreservation of adipose-derived mesenchymal stem cells' with the Japan-based Welfare Association.

Next Daily, Kang Min-jin, Reporter, 2024.02.16

Original article:http://www.nextdaily.co.kr